Undergraduate medical school education in substance misuse in Britain III: Can medical students drive change?

Drugs: Education, Prevention and Policy

Volumn 11, Issue 6, 2004, Pages 483-503

  Crome, Ilana B ^a   Shaikh, Nasreen ^b  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8744257463     PISSN: 09687637     EISSN: None     Source Type: Journal    
DOI: 10.1080/09687630410001701322     Document Type: Article

References (85)

1. ABDULRAHIM, D., ANNAN, J., CYSTER, R. et al. (2001). Developing an integrated model of care for drug treatment: promoting quality, efficiency and effectiveness in drug misuse treatment services. London: National Treatment Agency.
2. ABED, R.T. & NEIRA-MUNOZ, E. (1990). A survey of general practitioners' opinions and attitudes to drug addicts and addiction. British Journal of Addiction, 85, 131-136.
3. AMATO, L., DAVOLI, M., FERRI, M. & ALI, R. (2003). Methadone at tapered doses for the management of opioid withdrawal (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
4. BAERHEIM, A. & MELAND, E. (2003). Medical students proposing questions for their own written final examination: evaluation of an educational project. Medical Education, 37, 734-738.
5. BAUMAN, A. & PHONGSAVAN, P. (1999). Epidemiology of substance use in adolescence: prevalence, trends and policy implications. Drug & Alcohol Dependence, 55, 187-207.
6. BEST, D., RAWAF, S., ROWLEY, J., FLOYD, K., MANNING, V. & STRAN, J. (2000). Drinking and smoking as concurrent predictors of illicit drug use and positive drug attitudes in adolescents. Drug and Alcohol Dependence, 60, 319-321.
7. BIEN, T.H., MILLER, W.R. & TONIGAN, J.S. (1993). Brief interventions for alcohol problems: a review. Addiction, 88, 315-336.
8. BROWNELL, L.W. & NAIK, P.C. (2003). Services for opiate misuse: can primary care meet government expectations? Psychiatric Bulletin, 27, 328-330.
9. CABINET OFFICE (1998). Tackling drugs to build a better Britain: the Government's 10-year strategy for tackling drug misuse. London: The Stationery Office.
10. CABINET OFFICE (2001). United Kingdom anti-drugs co-ordinator's annual report 2000/01. London: Home Office.
11. CABINET OFFICE (2004). Alcohol harm reduction strategy for England. London: Home Office.
12. CANNING, U.P., KENNELL-WEBB, S.A., MARSHALL, E.J., WESSELY, S.C. & PETERS, T.J. (1999). Substance misuse in acute general medical admissions. Quarterly Journal of Medicine, 92, 219-326.
13. COHEN, J., RUNCIMAN, R., & WILLIAMS, R. (1999). Substance use and misuse in psychiatric wards. Drugs: education, prevention and policy, 6, 181-194.
14. COULTHARD, M., FARRELL, M., SINGLETON, N. & MELTZER, H. (2002). Tobacco, alcohol and drug use and mental health. London: The Stationery Office.
15. CRAWFORD, V., CLANCY, C. & CROME, I.B. (2003). Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs: education, prevention and policy, 10 (Suppl., S1-S74).
16. CRISP, A.H., GELDER, M.G., RIX, S., MELTZER, H.I. & ROWLANDS, O.J. (2000). Stigmatisation of people with mental illnesses. British Journal of Psychiatry, 177, 4-7.
17. CROME, I.B. (1999). The trouble with training: substance misuse education in British medical schools revisited. What are the issues? Drugs: education, prevention and policy, 6, 111-123.
18. CROME, I.B. & DAY, E. (1999). Substance misuse and dependence: older people deserve better services. Reviews in Clinical Gerontology, 9, 327-342.
19. DEPARTMENT OF HEALTH (1999a). Guidelines on clinical management: drug misuse and dependence. Norwich: The Stationery Office.
20. DEPARTMENT OF HEALTH (1999b). The national service framework for mental health. London: Department of Health.
21. DEPARTMENT OF HEALTH (2001a). Shifting the balance of power within the NHS. London: Department of Health.
22. DEPARTMENT OF HEALTH (2001b). The mental health policy implementation guide. London: Department of Health.
23. DEPARTMENT OF HEALTH (2003). National alcohol harm reduction strategy: interim analytical report. At www.number10.gov.uk/output/page4498.asp
24. DIERKER, L., AVENOLI, S., MERIKANGAS, K., FLAHERTY, B.P. & STOLAR, M. (2001). Association between psychiatric disorders and the progression of tobacco use behaviours. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1159-1167.
25. DUKES, P.J., PANTELIS, C., MCPHILLIPS, M.A. & BARNES, T.R.E. (2001). Comorbid non-alcohol substance misuse among people with schizophrenia. British Journal of Psychiatry, 179, 509-513.
26. EDWARDS, G., ANDERSON, P., BABOR, T.F. & BARNES, T.R.E. (1994). Alcohol and the public good. Oxford: Oxford University Press.
27. EL-GUEBALY, N., TOEWS, J., LOCKYER, J., ARMSTRONG, S. & HODGINS, D. (2000). Medical education in substance-related disorders: components and outcome. Addiction, 95, 949-957.
28. FRISCHER, M., HICKMAN, M., KRAUS, L., MARIANI, F. & WIESSING, L. (2001). A comparison of different methods for estimating the prevalence of problematic drug use in Great Britain. Addiction, 96, 1465-1476.
29. FUCITO, L.M., GOMES, B.S., MURNION, B., HABER, P. & FUCITO, L. (2003). General practitioners' diagnostic skills and referral practices in managing patients with drug and alcohol-related health problems: implications for medical training and education programmes. Drug and Alcohol Review, 22, 417-424.
30. GENERAL MEDICAL COUNCIL (2003). Tomorrow's doctors: recommendations on undergraduate medical education. London: General Medical Council.
31. GFROERER, J., PENNE, M., PEMBERTON, M. & FOLSOM, R. (2003). Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug and Alcohol Dependence, 69, 127-135.
32. GHODSE, A.H. & HOWSE, K. (1994). Substance use of medical students: a nationwide survey. Health Trends, 26B, 85-88.
33. GILBERT, P. (2003). Stigmatisation as a survival strategy: 'skeletons in the cupboard' and the role of shame. In A. Crisp (ed.), Every family in the land: tackling prejudice and discrimination against people with mental illness. At www.stigma.org
34. GLASS, I.B. (1989). Undergraduate training in substance abuse in the United Kingdom. British Journal of Addiction, 84, 197-202.
35. GOPALAN, R., SANTORA, P., STOKES, E.J. et al. (1992). Evaluation of a model curriculum on substance abuse at the Johns Hopkins University School of Medicine. Academic Medicine, 67, 260-266.
36. Gossop, M. & STRANG, J. (2000). Price, cost and value of opiate detoxification treatments: reanalysis of data from two randomised trials. The British Journal of Psychiatry, 177, 262-266.
37. GOWING, L., ALI, R. & WHITE, J. (2003). Buprenorphine for the management of opioid withdrawal (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
38. HARRIS, J.R., SCHAUFFLER, H.-H., MILSTEIN, A., POWERS, P. & HOPKINS, D.P. (2001). Expanding health insurance coverage for smoking cessation. American Journal of Health Promotion, 15, 350-356.
39. HEALTH ADVISORY SERVICE (2001a). Substance misuse and mental health comorbidity (dual diagnosis): standards for mental health services. London: Health Advisory Service.
40. HEALTH ADVISORY SERVICE (2001b). The substance of young needs. London: The Home Office Drugs Prevention Advisory Service.
41. HEATHER, N. (1996). The public health and brief interventions for excessive alcohol consumption: the British experience. Addictive Behaviors, 21, 857-868.
42. HIPWELL, A.E., SINGH, K. & CLARK, A. (2000). Substance misuse among clients with severe and enduring mental illness: service utilisation and implications for clinical management. Journal of Mental Health, 9, 37-50.
43. HODGSON, R.J., JOHN, B., ABBASI, T., HODGSON, R.C., WALLER, S., THORN, B. & NEWCOMBE, R.G. (2003). Fast screening for alcohol misuse. Addictive Behaviors, 28, 1453-1463.
44. HOFF, R.A. & ROSENHECK, R.A. (1999). The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Medical Care, 356, 835-843.
45. HOWSE, K. & GHODSE, A.H. (1997). Hazardous drinking and its correlates among medical students. Addiction Research, 4, 355-366.
46. INSTITUTE OF MEDICINE (1990). Broadening the base of treatment for alcohol problems. Washington, DC: National Academy Press.
47. ISAACSON, J.H., FLEMING, M., KRAUS, M. et al. (2000). A national survey of training in substance use disorders in residency programs. Journal of Studies on Alcohol, 61, 912-915.
48. KAKKO, J., DYBRANDT SVANBORG, K., KREEK, M.J. & HEILIG, M. (2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. The Lancet, 361, 662-668.
49. KENDALL, P.C. & CLARKIN, J.F. (1992). Introduction to special section: comorbidity and treatment implications. Journal of Consulting and Clinical Psychology, 60, 833-834.
50. KIRCHMAYER, U., DAVOLI, M. & VERSTER, A. (2003). Naltrexone maintenance treatment for opioid dependence (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
51. LANCET (2001). Editorial: reducing the stigma of mental illness. The Lancet, 357, 1055.
52. LARSSON, S. (1999). Scandinavia. In A. McNeill (ed.), Medical education in alcohol and alcohol problems: a European perspective (pp. 31-32). St Ives: Eurocare.
53. LEWIS, G. & DRIFE, J. (eds) (2002). Why mothers die 1997-1999. The fifth report of the confidential enquiries into maternal deaths in the United Kingdom. London: Royal College of Obstetricians and Gynaecologists.
54. LIMA, A.R., LIMA, M.S., SOARES, B.G.O. & FARRELL, M. (2003a). Carbamazepine for cocaine dependence (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
55. LIMA, M.S., REISSER, A.A.P., SOARES, B.G.O. & FARRELL, M. (2003b). Antidepressants for cocaine dependence (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
56. MATTICK, R.P., BREEN, C., KIMBER, J. et al. (2003a). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
57. MATTICK, R.P., KIMBER, J., BREEN, C. & DAVOLI, M. (2003b). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
58. MCCRONE, P., MENEZES, P.R., JOHNSON, S., SCOTT, H., THORNICROFT, G., MARSHALL, J., BEBBINGTON, P. & KUIPERS, E. (2000). Service use and costs of people with dual diagnosis in South London. Acta Psychiatrica Scandinavica, 101, 464-472.
59. MCNEILL, A. (ed.) (1999). Medical education in alcohol and alcohol problems: a European perspective. St Ives: Eurocare.
60. MENEZES, P.R., JOHNSON, S., THORNICROFT, G., MARSHALL, J., PROSSER, D., BEBBINGTON, P. & KUIPERS, E. (1996). Drug and alcohol problems among individuals with severe mental illnesses in south London. British Journal of Psychiatry, 168, 612-619.
61. NEWBURY-BIRCH, D., WALSHAW, D. & KAMALI, F. (2001). Drink and drugs: from medical students to doctors. Drug and Alcohol Dependence, 64, 265-270.
62. NICE (2002). Technology appraisal guidance No. 38: nicotine replacement therapy (NRT) and bupropion for smoking cessation. London: National Institute for Clinical Excellence.
63. OYEFESO, A., GHODSE, H., CLANCY, C. et al. (1999). Drug misuse-related mortality: a study of teenage addicts over a 20-year period. Social Psychiatry and Psychiatric Epidemiology, 34, 437-441.
64. PARTHASARATHY, S., WEISNER, C., HU, T.W. & MOORE, C. (2001). Association of out-patient alcohol and drug treatment with health care utilisation and cost: revisiting the offset hypothesis. Journal of Studies on Alcohol, 62, 89-97.
65. PICKARD, M., BATES, L., DORIAN, M., GREIG, H. & SAINT, D. (2000). Alcohol and drug use in second year medical students at the University of Leeds. Medical Education, 34, 148-150.
66. PROCHASKA, J.O. & DICLEMENTE, C.C. (1982). Transtheoretical theory: towards a more integrative model of change. Psychotherapy: Theory, Research and Practice, 19, 276-288.
67. PROJECT MATCH RESEARCH GROUP (1997a). Matching alcoholism treatments to client heterogeneity: project MATCH post-treatment drinking outcomes. Journal of Studies on Alcohol, 58, 7-29.
68. PROJECT MATCH RESEARCH GROUP (1997b). Project MATCH secondary a priori hypotheses. Addiction, 92, 1671-1698.
69. RAW, M., MCNEILL, A. & WEST, R. (1998). Smoking cessation guidelines for health professionals, a guide to effective smoking cessation interventions for the health care system. Thorax, 53 (Suppl. 5, S1-S38).
70. ROLLNICK, S., HEATHER, N., GOLD, R. & HALL, W. (1992). Development of a short 'readiness to change questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction, 87, 743-754.
71. ROYAL COLLEGE OF PHYSICIANS (2000). Nicotine addiction in Britain. London: Royal College of Physicians.
72. ROYAL COLLEGE OF PSYCHIATRISTS (2001). Role of consultants with responsibility for substance misuse (addiction psychiatrists). Council Report CR97. London: Royal College of Psychiatrists.
73. ROYAL COLLEGE OF PSYCHIATRISTS (2002). Advice to commissioners and purchasers of modern substance misuse services. Council Report CR100. London: Royal College of Psychiatrists.
74. ROYAL COLLEGE OF PSYCHIATRISTS (2004). The mental health of students in higher education. Council Report CR112. London: Royal College of Psychiatrists.
75. RYCHLIK, R., SIEDENTOP, H., PFEIL, T. & DANIEL, D. (2003). Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent persons. European Addiction, 9, 59-64.
76. SCHUMACHER, J.E., MENNEMEYER, S.T., MILBY, J.B., WALLACE, D. & NOLAN, K. (2002). Costs and effectiveness of substance abuse treatments for homeless persons. The Journal of Mental Health Policy and Economics, 5, 33-42.
77. SHAKESHAFT, A.P., BOWMAN, J.A., BURROWS, S., DORAN, C.M. & SANSON-FISHER, R.W. (2002). Community-based alcohol counselling: a randomized clinical trial. Addiction, 97, 1449-1463.
78. SRISURAPANONT, M., JARUSURAISIN, N. & KITTIRATTANAPAIBOON, P. (2003a). Treatment for amphetamine dependence and abuse (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
79. SRISURAPANONT, M., JARUSURAISIN, N. & KITTIRATTANAPAIBOON, P. (2003b). Treatment for amphetamine withdrawal (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
80. SRISURAPANONT, M., KITTIRATTANAPAIBOON, P. & JARUSURAISIN, N. (2003c). Treatment for amphetamine psychosis (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software.
81. ULRICH, J., HILL, A., RUMPF, H.-J., HAPKE, U. & MEYER, C. (2003). Alcohol high risk drinking, abuse and dependence among tobacco smoking medical care patients and the general population. Drug and Alcohol Dependence, 69, 189-195.
82. VUORI, E., HENRY, J.A., OJANPERÄ, I., NIEMINEN, R., SAVOLAINEN, T., WAHLSTEN, P. & JÄNTTI, M. (2003). Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction, 98, 365-368.
83. WEISNER, C., MERTENS, J., PARTHASARATHY, S., MOORE, C. & LU, Y. (2001). Integrating primary medical care with addiction treatment: a randomized controlled trial. Journal of the American Medical Association, 286, 1715-1723.
84. WRIGHT, S., GOURNAY, K., GLORNEY, E. & THORNICROFT, G., (2000). Dual diagnosis in the suburbs: prevalence, need and in-patient service use. Social Psychiatry and Psychiatric Epidemiology, 35, 397-404.
85. WU, L.-T., KOUZIS, A.C. & LEAF, P.J. (1999). Influence of comorbid alcohol and psychiatric disorders on utilisation of mental health services in the national comorbidity survey. American Journal of Psychiatry, 156, 1230-1236.